Page last updated: 2024-12-11

calythropsin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

calythropsin: structure given in first source; isolated from Calythropsis aurea [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Calythropsis aureaspecies[no description available]MyrtaceaeThe myrtle plant family of the order Myrtales. It includes several aromatic medicinal plants such as EUCALYPTUS.[MeSH]

Cross-References

ID SourceID
PubMed CID5353470
CHEMBL ID340244
CHEBI ID178325
SCHEMBL ID23849534
MeSH IDM0226072

Synonyms (15)

Synonym
calythropsin
3-(3,4-dihydroxy-phenyl)-1-(2-hydroxy-4-methoxy-phenyl)-propenone
bdbm50042972
2-propen-1-one, 3-(3,4-dihydroxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)-, (e)-
CHEBI:178325
152340-67-5
(e)-3-(3,4-dihydroxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one
MEGXP0_000779
LMPK12120115
nsc692204
nsc-692204
CHEMBL340244 ,
SCHEMBL23849534
CS-0834509
HY-N11766

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
chalconesA ketone that is 1,3-diphenylpropenone (benzylideneacetophenone), ArCH=CH(=O)Ar, and its derivatives formed by substitution.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)IC50 (µMol)0.01500.00462.018210.0000AID6820
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID6820In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined1993Journal of medicinal chemistry, Nov-26, Volume: 36, Issue:24
3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors.
AID335767Cytotoxicity against human NCI60 cells after 2 days by XTT assay1993Journal of natural products, Oct, Volume: 56, Issue:10
Two new cytotoxic chalcones from Calythropsis aurea.
AID161166Inhibition of Prostaglandin G/H synthase activity in sheep seminal vesicle was determined1993Journal of medicinal chemistry, Nov-26, Volume: 36, Issue:24
3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors.
AID1832963Cytotoxicity against mouse J774A.1 cells assessed as reduction in cell viability at 10 uM after 24 hrs by MTT assay2021Bioorganic & medicinal chemistry, 11-01, Volume: 49Design, synthesis and bioactivity evaluation of fisetin derivatives as potential anti-inflammatory agents against LPS-induced acute lung injury.
AID1832961Antiinflammatory activity in mouse J774.A1 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 10 uM incubated for 2 followed by LPS stimulation and measured after 22 hrs by ELISA relative to control2021Bioorganic & medicinal chemistry, 11-01, Volume: 49Design, synthesis and bioactivity evaluation of fisetin derivatives as potential anti-inflammatory agents against LPS-induced acute lung injury.
AID1832962Antiinflammatory activity in mouse J774.A1 cells assessed as inhibition of LPS-induced IL6 secretion at 10 uM incubated for 2 followed by LPS stimulation and measured after 22 hrs by ELISA relative to control2021Bioorganic & medicinal chemistry, 11-01, Volume: 49Design, synthesis and bioactivity evaluation of fisetin derivatives as potential anti-inflammatory agents against LPS-induced acute lung injury.
AID335768Cytotoxicity against mouse L1210 cells after 24 hrs1993Journal of natural products, Oct, Volume: 56, Issue:10
Two new cytotoxic chalcones from Calythropsis aurea.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.87 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]